knowledge -WSS

knowledge

author：hotspot 2025-09-28 00:49:38 - browse：936

Erik Tokat -- biotech JPM coverage from STAT — Eric Tokat is co-president of investment banking at Centerview Partners. Courtesy Centerview Partners

SAN FRANCISCO — Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another strong year for acquisitions, driven by Big Pharma’s need to restock pipelines with medicines that can generate sales in the coming years.

That’s not idle speculation. It’s perhaps as close to a guarantee one can get in biotech. Last year, Tokat’s advisory firm, Centerview Partners, was involved in 19 of the 23 biotech transactions valued at $1 billion or more. Two more acquisitions of Centerview clients — Harpoon Therapeutics and Ambrx Biopharma — were announced Monday morning.

“I’m not sure if we’re going to have 23 deals or 25 deals, but I think it’s going to be a good year,” said Tokat, speaking to STAT over coffee on the sidelines of the J.P. Morgan Healthcare Conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Medicare drug price negotiation’s day in court

leisure time

WSS

General Catalyst, Summa Health deal will turn on physician buy

General Catalyst, Summa Health deal will turn on physician buy

Lecanemab for Alzheimer's is coming. Is the health system ready?

Study: Pain burden is higher in Black NFL players than white ones

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Iowa House, Senate pass 6

entertainment

knowledge

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

SAMSHA loosens regulations on methadone treatment centers

Malaria cases in Florida and Texas: Here’s what you need to know

What to know about OceanGate, the company behind the missing Titanic submersible

The high cost of giving birth even with insurance

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Wildfire smoke exposes gaps in outdoor worker protections

N.Y. state detects polio case, first in the U.S. since 2013

hotspot

Congressmen charge Covid hearing ‘could have been an email’

Biden administration opens offers in Medicare drug price negotiations

ARCH Venture Partners is raising $3 billion for a life sciences fund

Juul spent big to court Black leaders to promote its e

Why 40% Americans with Parkinson’s don’t see a neurologist

ARCH Venture Partners is raising $3 billion for a life sciences fund

entertainment

leisure time

explore

focus